The genus Gentiana is one of the largest genera in the Gentianaceae family. Many Gentiana species have been scientifically investigated for their chemical constituents and chemotaxonomic sense. To date, more than 500 chemical compounds were isolated from Gentiana plant. Several researchers have reviewed the secondary metabolites and their bioactivities of Gentiana plants. However, a survey on iridoid glycosides and their chemotaxonomic sense of the genus Gentiana are unavailable. Iridoid glycosides are the major chemicals isolated from Gentiana spp., which serve as potential chemotaxonomic markers to differentiate Gentiana species. Herein, the review systematically summarizes the scaffolds of the iridoids reported according to the biosynthetic pathway of natural iridoid glycosides. Furthermore, the taxonomy of Gentiana and chemotaxonomic sense of iridoid glycosides in the genus Gentiana were surveyed.

No abstract

The twenty-first century has already recorded more than ten major epidemics or pandemics of viral disease, including the devastating COVID-19. Novel effective antivirals with broad-spectrum coverage are urgently needed. Herein, we reported a novel broad-spectrum antiviral compound PAC5. Oral administration of PAC5 eliminated HBV cccDNA and reduced the large antigen load in distinct mouse models of HBV infection. Strikingly, oral administration of PAC5 in a hamster model of SARS-CoV-2 omicron (BA.1) infection significantly decreases viral loads and attenuates lung inflammation. Mechanistically, PAC5 binds to a pocket near Asp49 in the RNA recognition motif of hnRNPA2B1. PAC5-bound hnRNPA2B1 is extensively activated and translocated to the cytoplasm where it initiates the TBK1-IRF3 pathway, leading to the production of type I IFNs with antiviral activity. Our results indicate that PAC5 is a novel small-molecule agonist of hnRNPA2B1, which may have a role in dealing with emerging infectious diseases now and in the future.

No abstract